Polymer extrusion manufacturer and material science innovator Zeus, has announced it has acquired medical device components manufacturer MWC Technologies.
M&A
Zeus, which is exhibiting at MD&M East this week states that the acquisition supports the company's growth strategy and adds to its capabilities that it has been developing for the past five decades.
The acquisition will allow for the global commercialisation of the many cutting-edge, solution-driven products in MWC’s portfolio.
Frank P. Tourville, founder and chairman of the Board, Zeus, said: “Since I founded the company in 1966, Zeus has been focused on continuing to grow and innovate. This acquisition supports those goals. We are confident that our acquisition of MWC will provide value to our customers today and into the future.”
John Winarchick, CEO, Zeus, said: “The acquisition of MWC will expand our capabilities and product portfolio to address the rising demand for advanced precision extrusions. Our combined expertise will enhance our ability to better serve customers around the globe.”
“We are excited to be joining the Zeus team! Zeus’s long-term commitment to industry leading quality, customer service and innovation aligns well with MWC’s culture. Our combined technologies will enable new to the market solutions for our customers.” said Eric Avans, quality manager, MWC Technologies.